susan wood vida

18 months after her terrible fall, broadcaster Susan Wood opens about her tough journey to recovery and on re-learning how to walk and talk all over again. Wood, Ph.D., as president and chief executive officer. View Susan Wood's business profile as President & Chief Executive Officer at Vida Diagnostics. "John Garber successfully executed on the founders vision and established a tremendous platform for VIDA, tapping into one of the world's most talented teams of engineers, physiologists and clinicians focused exclusively on pulmonary imaging. For more information on VIDA Diagnostics, visit: http://www.vidadiagnostics.com/.

W250 BioVentures Center

Our guest is Dr. Susan Wood, President, and CEO of VIDA Diagnostics in Coralville Iowa, she speaks with Chris Wood, Intelerad Chief Technology Officer. United States. VIDA provides the new standard of pulmonary care by using AI-powered CT imaging software and services to aid the early detection, evaluation, and treatment planning of patients with or at risk of respiratory and lung diseases, including emphysema and... Information without innovation is just data, Susan Wood’s role in Vida Diagnostics is President & Chief Executive Officer, Susan Wood’s email address is s***@vidadiagnostics.com, Susan Wood’s business email address is s***@vidadiagnostics.com, Susan Wood’s direct phone number is (855) ***-****, Susan Wood’s HQ phone number is (319) 335-4740, Susan Wood’s latest job experience is Executive VP, Marketing & Technology at Vital Images, Susan Wood’s latest education in Master of Science - at Duke University. Bringing extensive clinical and commercial expertise in quantitative thoracic image analysis, Dr. Wood will focus on the continued development and commercialization of the Company's FDA-cleared pulmonary applications and establishing quantitative pulmonary imaging into routine clinical practice. CONTACT: Chris K. Joseph +1-510-339-2293, chris@ckjcomm.com, for VIDADiagnostics, Web site: http://www.vidadiagnostics.com//, © 1985 - 2020 BioSpace.com. With Lana Turner, John Gavin, Sandra Dee, Susan Kohner. According to the National Heart, Lung and Blood Institute (NHLBI), COPD is the fourth leading cause of death in the United States and the only major cause of death that is still growing in mortality rate. VIDA’s LungPrint AI solution identifies a unique patient profile and optimizes workflows for the pulmonary patient in both clinical trials and clinical care. The Company offers imaging services such as detection, evaluation, and treatment of pulmonary diseases. Dr. Wood most recently held the position of executive Vice President of Marketing and Technology for Vital Images, an innovative software company specializing in cardiovascular applications for advanced analysis software. Dr Wood is a member of the board of directors of iCAD (NASDAQ:ICAD), a clinical AI company with initial focus in women’s health. Stream Susan Wood, VIDA Diagnostics by Technically Iowa from desktop or your mobile device

Dr. Wood succeeds John Garber, who during his tenure helped build VIDA from an academic concept to the leading pulmonary image analysis tool in clinical research. Wood , PhD President & Chief Executive Officer Dr. Wood has 15+ years of experience championing innovative clinical solutions to the mark, SUSAN A. Dr. Wood has been issued multiple patents in the field of computer-aided detection, quantitative imaging and AI; authored numerous book chapters, peer-reviewed papers, abstracts in the field. In this episode, we learn how VIDA Diagnostics has developed an AI-powered lung imaging analytics solutions to profile and manage patients that are at risk of respiratory diseases, including COPD and COVID-19. President and Chief Executive Officer of Vital Images Inc. www.vbprofiles.com is now www.topionetworks.com. Season 2 – Episode 2 – Interview with Dr. Susan Wood (VIDA), Season 3 – Episode 1 – Interview with Dr. Brown of Carolina Radiology Associates, Season 2 – Episode 3 – Interview with Jason Layne (Radius), Season 2 – Episode 1 – Interview with Dr. Mark Nigogosyan, Episode 4 – Interview with Dr. Scott Henneman. Founded by four University of Iowa faculty members, Eric Hoffman, Ph.D., Geoffrey McLennan, M.D., Ph.D., Joseph Reinhardt, Ph.D and, Milan Sonka, Ph.D., VIDA Diagnostics is based on research associated with the UI's Iowa Comprehensive Lung Imaging Center directed by Dr. Hoffman and on core technology licensed from the UI Research Foundation. Technically Iowa Podcast is sponsored by the Iowa Economic Development Authority (IEDA). Director, Customer Success & Information Tech... Director, Engineering & Clinical Application ... Profiles With a Similar Job Title And Industry, Profiles With a Similar Job Title And Location. Dr. Wood has 20+ years of experience championing clinical imaging-based AI and predictive analytic solutions from concept through market acceptance. Precision, Commercial Operations Specialist.

Susan Wood works in the industry of Software Development & Design, Software. Join to Connect.

We are delighted to add her domain knowledge and industry experience to further build on VIDA's leadership position, and to establish objective, quantitative measures for diagnosis, interventional therapies and therapeutic response assessment," said Geoffrey McLennan, M.D., Ph.D., a founder of VIDA and a practicing pulmonologist at the University of Iowa Healthcare.

VIDA Diagnostics, Inc. Based on the quality and frequency of confirmatory data points, this metric represents the likelihood that a contact is employed where we say they are and that it is possible to reach them via email, "We're living in the age of personalized medicine, where precision algorithms can be used to optimize outcomes for patients," said Susan Wood , PhD, p, Susan A. VIDA’s LungPrint AI solution identifies a unique patient profile… VIDA Diagnostics serves customers in the State of Iowa. What is Susan Wood’s latest job experience? IOWA CITY, Iowa, Sept. 28 /PRNewswire/ -- VIDA Diagnostics, a leading developer of quantitative imaging software for the advanced analysis of pulmonary diseases, such as Chronic Obstructive Pulmonary Disease (COPD), asthma and lung cancer, announced today the appointment of Susan A. Her Ph.D. work combined quantifying three-dimensional lung structure with changes in lung function using high-resolution CT imaging. Wood, Ph.D., as president and chief executive officer.

Find contact's direct phone number, email address, work history, and more. Participating in the emerging pulmonary device market that is expected to grow to nearly $3.8 billion by 2011, VIDA's vision is to establish lung quantitative CT methods as the standard of care for diagnosis and staging of chronic lung disease. Her Ph.D. work combined quantifying three-dimensional lung structure with changes in lung function in health and disease, using high-resolution CT imaging. Dr. Wood is president and CEO of VIDALung.ai, a clinical AI company with focus on intelligent management of patients with or at risk of pulmonary disease. Learn why Frost & Sullivan named VIDA 2020 Company of the Year. Lung cancer remains the most common cause of cancer death in both men and women.

Hello world!

Click to share thisClick to share this